Navigation Links
National Lung Cancer Partnership and LUNGevity Foundation
Date:3/16/2008

MADISON, Wis. National Lung Cancer Partnership, in partnership with the LUNGevity Foundation, is pleased to announce the winners of their third annual research grant competition.

The research grants, each $100,000, were created to advance research in basic lung cancer biology, risk assessment, prevention, detection, and response to treatment. With the support of Genentech and our very generous donors, were able to offer researchers critical funding when choosing to investigate this deadly disease, said Regina Vidaver, executive director of National Lung Cancer Partnership.

Hildegard Schuller, M.D., Ph.D., of the University of Tennessee is the recipient of a research grant for advancing the understanding of sex differences in lung cancer. Dr. Schullers research will evaluate the relationship between estrogen and the nicotine-derived carcinogen, NNK, in lung tumor formation. She hypothesizes that estrogen and NNK cause more DNA damage in lung cells than NNK alone.

Understanding the basic mechanisms of estrogens influence in lung carcinogenesis should provide new targets for early diagnosis, prevention, and therapy, said Dr. Schuller.

The second grant recipient is Albert Baldwin, Ph.D. of the Lineberger Cancer Center at the University of North Carolina at Chapel Hill. Dr. Baldwin will study molecules involved in the regulation of normal cell growth. When mutated, some of these molecules can cause normal cells to begin growing out of control, and can lead to cancer. In addition, he will investigate drugs that can block steps governing uncontrolled cell growth, with the goal of blocking lung tumor initiation and growth.

Our goal is to increase the understanding of the development of lung cancer and to improve lung cancer treatment, said Dr. Baldwin. We are hopeful that the studies will lead to new therapeutic options for a large number of lung cancer patients.

Lung cancer research is severely under-fund
'/>"/>

Contact: Sara Conley
sconley@pcipr.com
312-558-1770
National Lung Cancer Partnership
Source:Eurekalert

Page: 1 2

Related biology news :

1. Wolves find happy hunting grounds in Yellowstone National Park
2. BIO-key(R) International to Showcase Deployed Biometric Security Applications at 2007 Biometric Technology Expo
3. ESMO International Symposium on Immunology
4. Story tips from the US Department of Energys Oak Ridge National Laboratory, September 2007
5. Office of the Director of National Intelligence, CIO to Speak at Government Security Conference
6. Director of National Intelligence to Speak at Conference
7. Singapore National Science and Technology Awards
8. Conservation International and Toyota partner to protect Philippines rain forests
9. International team shows mercury concentrations in fish respond quickly to increased deposition
10. International team shows mercury concentrations in fish respond quickly to increased deposition
11. Office of the Director of National Intelligence, CIO to Speak at Government Security Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/21/2014)... 20, 2014 Strict laws against distracted driving ... the North American and European automotive sector towards gesture ... recognition systems that are intuitive and able to retrieve ... industry. New analysis from Frost & ... in Europe and ...
(Date:11/18/2014)... Nov. 18, 2014  The Secure Identity & ... today jointly announce the formation of The Airport ... its Identity and Biometric Entry and Exit ... received official support from BORDERPOL, the international non-profit ... and provide expertise regarding border security, traveler and ...
(Date:11/18/2014)... Nov. 18, 2014   EyeLock Inc. , ... and MorphoTrust USA (Safran), a leading ... announced a strategic partnership to offer comprehensive biometric ... administration (MVA), airport screening and financial services markets. ... MorphoTrust serves consumers through a nationwide network of ...
Breaking Biology News(10 mins):Gesture Recognition Intensifies with the Rise of In-car Smartphone Integration, Says Frost & Sullivan 2Gesture Recognition Intensifies with the Rise of In-car Smartphone Integration, Says Frost & Sullivan 3Gesture Recognition Intensifies with the Rise of In-car Smartphone Integration, Says Frost & Sullivan 4Identity Management, Document Authentication and Biometric Companies Form "The Airport Entry and Exit Working Group", Releasing the Framework to Help Guide the Department of Homeland Security and Congress Towards Solutions 2Identity Management, Document Authentication and Biometric Companies Form "The Airport Entry and Exit Working Group", Releasing the Framework to Help Guide the Department of Homeland Security and Congress Towards Solutions 3EyeLock, MorphoTrust Form Strategic Partnership to Pursue Commercial Enterprise Deployments 2EyeLock, MorphoTrust Form Strategic Partnership to Pursue Commercial Enterprise Deployments 3
... dioxide levels will reduce the density of coral skeletons, making ... a new study of corals growing where submarine springs naturally ... by researchers at the University of California, Santa Cruz, and ... Sciences ( PNAS ), is the first to show ...
... excess energy through the production of hydrogen. Biologists at the Ruhr-Universitt ... oxygen. For this, they need the messenger molecule nitric oxide and ... of humans. With colleagues at the UC Los Angeles, the Bochum ... an old protein in a new look In ...
... Yehia, M.D., M.P.P., M.S.H.P., Department of Medicine at the ... Health Equity Research and Promotion (CHERP), has received a ... and leadership in the field of HIV health services ... health outcomes of individuals living with chronic viral diseases ...
Cached Biology News:Submarine springs reveal how coral reefs respond to ocean acidification 2When green algae run out of air 2The American Society for Microbiology honors Baligh Yehia 2
(Date:12/22/2014)... CHAPEL HILL, N.C. , Dec. 22, 2014 ... ALNE) today announced that it has signed a ... biotechnology company that has developed and patented a ... and medical diagnostics products that enable rapid on-site ... and alcohol use/abuse and health issues in an ...
(Date:12/22/2014)... The American Journal of Hematology/Oncology, a ... editorials addressing developments and pathways related to oncological ... article exploring the role of follicle-stimulating hormone (FSH) ... prostate cancer. , The article references seminal ... there could be a connection to prostate cancer ...
(Date:12/19/2014)... Hershey, PA (PRWEB) December 19, 2014 ... a leading developer and manufacturer of needle-free injection ... an agreement with Immunomic Therapeutics, Inc. (“ITI”) for ... injection device with its LAMP™ vaccine platform. ... for an exclusive Worldwide license to the Biojector®-2000 ...
(Date:12/19/2014)... 2014 Naurex Inc., a biopharmaceutical company leveraging ... of the central nervous system, today announced that ... will present at the 33 rd annual J.P. ... at 3:00 p.m. PST on Tuesday, January 13, 2015, ... Francisco, Calif. About Naurex ...
Breaking Biology Technology:ALNE Announces Intention To Acquire BioTechPharma 2Prostate Cancer Experts Dissect the Role of Follicle-stimulating Hormone in the Development, Progression and Potential Treatment of Prostate Cancer 2Prostate Cancer Experts Dissect the Role of Follicle-stimulating Hormone in the Development, Progression and Potential Treatment of Prostate Cancer 3Prostate Cancer Experts Dissect the Role of Follicle-stimulating Hormone in the Development, Progression and Potential Treatment of Prostate Cancer 4Bioject and Immunomic Therapeutics Enter into an Agreement for License of Needle-Free Technology for LAMP-vax Vaccines 2Bioject and Immunomic Therapeutics Enter into an Agreement for License of Needle-Free Technology for LAMP-vax Vaccines 3Naurex to Present at 33rd Annual J.P. Morgan Healthcare Conference 2
... CV Therapeutics,Inc. (Nasdaq: CVTX ) announced today ... of Cardiology Foundation and the American Heart,Association and ... that,"ranolazine may be safely administered for symptom relief ... indicated for the,treatment of chronic angina in patients ...
... Million ... profit increases 18% to $2.2 Million for Q2 of 2007 versus $1.9 ... Million for Q2 of 2006,-- Announces LOI to Restructure $11.5 Million of Debt to Equity and Acquire ... Remaining 49% of Erye, BEIJING, Aug. 15 /Xinhua-PRNewswire-FirstCall/ -- China,Biopharmaceuticals Holdings, Inc. ...
... ANNAPOLIS, Md., Aug. 13 PharmAthene, Inc.,(Amex: ... medical,countermeasures against biological and chemical threats, announced today,that ... Court to,affirm the validity of the merger between ... the Court of Chancery will determine that the ...
Cached Biology Technology:Ranexa(R) Added to New ACC/AHA Guidelines on Unstable Angina/Non ST-Elevation Myocardial Infarction (UA/NSTEMI) 2China Biopharmaceuticals Holdings Announces Second Quarter 2007 Financial Results 2China Biopharmaceuticals Holdings Announces Second Quarter 2007 Financial Results 3China Biopharmaceuticals Holdings Announces Second Quarter 2007 Financial Results 4China Biopharmaceuticals Holdings Announces Second Quarter 2007 Financial Results 5China Biopharmaceuticals Holdings Announces Second Quarter 2007 Financial Results 6China Biopharmaceuticals Holdings Announces Second Quarter 2007 Financial Results 7China Biopharmaceuticals Holdings Announces Second Quarter 2007 Financial Results 8China Biopharmaceuticals Holdings Announces Second Quarter 2007 Financial Results 9China Biopharmaceuticals Holdings Announces Second Quarter 2007 Financial Results 10Proceedings to Affirm Merger Between PharmAthene and Healthcare Acquisition Corp Initiated in Delaware Chancery Court 2
Smac/DIABLO (mouse) (CT) rabbit polyclonal antibody...
... Rabbit polyclonal to Taura Syndrome ... for all tested applications). ... Synthetic peptide: VTNSEGSTIL MNDIPITNQN VVLSKNVTDN ... corresponding to N terminal amino ...
Purified Mouse anti-Hu Actopaxin (pS8) Storage Temperature: Refrigerate(2 to 8C)...
... The FastPlax Antibody is used to detect ... the surface of infected cells as early ... basis of the FastPlax Titer Kit, which ... 25-48 hours. The FastPlax Antibody ...
Biology Products: